ID19755A - Komposisi untuk pemberian transdermal obat-obat steroid - Google Patents
Komposisi untuk pemberian transdermal obat-obat steroidInfo
- Publication number
- ID19755A ID19755A IDP980113A ID980113A ID19755A ID 19755 A ID19755 A ID 19755A ID P980113 A IDP980113 A ID P980113A ID 980113 A ID980113 A ID 980113A ID 19755 A ID19755 A ID 19755A
- Authority
- ID
- Indonesia
- Prior art keywords
- transdermal
- provision
- composition
- steroid medicines
- steroid
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019970002233A KR100215027B1 (ko) | 1997-01-27 | 1997-01-27 | 스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID19755A true ID19755A (id) | 1998-07-30 |
Family
ID=19495561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP980113A ID19755A (id) | 1997-01-27 | 1998-01-27 | Komposisi untuk pemberian transdermal obat-obat steroid |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1001812A1 (id) |
| JP (1) | JP2000508349A (id) |
| KR (1) | KR100215027B1 (id) |
| CN (1) | CN1244806A (id) |
| AR (1) | AR011577A1 (id) |
| AU (1) | AU727811B2 (id) |
| BR (1) | BR9807009A (id) |
| CA (1) | CA2277970A1 (id) |
| ID (1) | ID19755A (id) |
| RU (1) | RU2176499C2 (id) |
| TW (1) | TW537899B (id) |
| WO (1) | WO1998032465A1 (id) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100294084B1 (ko) * | 1998-06-02 | 2001-09-22 | 성재갑 | 비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형 |
| AU2223600A (en) * | 1999-01-06 | 2000-07-24 | Cedars-Sinai Medical Center | Hormone replacement for breast cancer patients |
| KR100403051B1 (ko) * | 2000-07-25 | 2003-10-23 | 일양약품주식회사 | 음낭 외 피부에 적용가능한 남성호르몬 경피흡수 패취제 |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| DE10107663B4 (de) * | 2001-02-19 | 2004-09-09 | Lts Lohmann Therapie-Systeme Ag | Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
| DE10163459A1 (de) * | 2001-12-21 | 2003-07-03 | Merck Patent Gmbh | Lyophilisierte Zubereitung enthaltend Antikörper gegen EGF-Rezeptor |
| AU2003296810A1 (en) * | 2002-12-10 | 2004-07-09 | Besins International Belgique | Pharmaceutical composition for transdermal or transmucous administration comprising a progestin or an estrogen, method for preparing same and uses thereof |
| FR2848112B1 (fr) * | 2002-12-10 | 2007-02-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations |
| FR2851470B1 (fr) | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
| JP4422430B2 (ja) * | 2003-05-14 | 2010-02-24 | 帝國製薬株式会社 | エストロゲン及び/又はプロゲストゲン含有外用貼付剤 |
| GB0409498D0 (en) * | 2004-04-28 | 2004-06-02 | Hunter Fleming Ltd | Transdermal steroid formulation |
| CN1313084C (zh) * | 2004-11-05 | 2007-05-02 | 郑会义 | 一种透皮避孕药传送体系及制备方法 |
| DE102004059880A1 (de) * | 2004-12-10 | 2006-06-14 | Grünenthal GmbH | Stabiles, hormonhaltiges (Zwischen-)Produkt |
| JP2007045808A (ja) * | 2005-01-07 | 2007-02-22 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
| JP4969050B2 (ja) * | 2005-01-07 | 2012-07-04 | ロート製薬株式会社 | 皮膚外用剤 |
| US10080760B2 (en) | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
| WO2013054809A1 (ja) * | 2011-10-14 | 2013-04-18 | 大正製薬株式会社 | 皮膚外用剤 |
| RS62297B1 (sr) | 2011-11-23 | 2021-09-30 | Therapeuticsmd Inc | Prirodne kombinovane hormonske supstitucione formulacije i terapije |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| JP5521025B2 (ja) * | 2012-12-21 | 2014-06-11 | 日本精化株式会社 | 浸透促進剤 |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| KR101968873B1 (ko) * | 2018-09-21 | 2019-04-29 | 아이큐어 주식회사 | 세포 침투 효과가 우수한 보툴리늄 유래 펩타이드를 포함하는 화장료 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
| JPH0744940B2 (ja) * | 1986-12-24 | 1995-05-17 | ライオン株式会社 | 口腔貼付用基材 |
| CH674618A5 (id) * | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
| CA1333114C (en) * | 1987-11-25 | 1994-11-15 | Daniel C. Duan | Pressure-sensitive adhesives and bioelectrodes constructed with the adhesive |
| US4906475A (en) * | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
| JP3238389B2 (ja) * | 1988-10-27 | 2001-12-10 | シエーリング アクチエンゲゼルシヤフト | ゲストデン含有の経皮適用のための薬剤 |
| DE3910578A1 (de) * | 1989-03-29 | 1990-10-04 | Schering Ag | Mittel zur transdermalen applikation enthaltend gestoden |
| US4973468A (en) * | 1989-03-22 | 1990-11-27 | Cygnus Research Corporation | Skin permeation enhancer compositions |
| EP0399432B1 (en) * | 1989-05-25 | 1994-06-22 | Takeda Chemical Industries, Ltd. | Transdermal therapeutic composition |
| US5314685A (en) * | 1992-05-11 | 1994-05-24 | Agouron Pharmaceuticals, Inc. | Anhydrous formulations for administering lipophilic agents |
-
1997
- 1997-01-27 KR KR1019970002233A patent/KR100215027B1/ko not_active Expired - Fee Related
-
1998
- 1998-01-23 BR BR9807009-6A patent/BR9807009A/pt not_active Application Discontinuation
- 1998-01-23 WO PCT/KR1998/000013 patent/WO1998032465A1/en not_active Ceased
- 1998-01-23 EP EP98902269A patent/EP1001812A1/en not_active Withdrawn
- 1998-01-23 CA CA002277970A patent/CA2277970A1/en not_active Abandoned
- 1998-01-23 RU RU99118582/14A patent/RU2176499C2/ru not_active IP Right Cessation
- 1998-01-23 JP JP10531848A patent/JP2000508349A/ja active Pending
- 1998-01-23 AU AU58820/98A patent/AU727811B2/en not_active Ceased
- 1998-01-23 CN CN98802010A patent/CN1244806A/zh active Pending
- 1998-01-26 TW TW087101089A patent/TW537899B/zh active
- 1998-01-27 ID IDP980113A patent/ID19755A/id unknown
- 1998-01-27 AR ARP980100352A patent/AR011577A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2277970A1 (en) | 1998-07-30 |
| WO1998032465A1 (en) | 1998-07-30 |
| KR19980066583A (ko) | 1998-10-15 |
| TW537899B (en) | 2003-06-21 |
| AU727811B2 (en) | 2000-12-21 |
| CN1244806A (zh) | 2000-02-16 |
| BR9807009A (pt) | 2000-03-14 |
| JP2000508349A (ja) | 2000-07-04 |
| AU5882098A (en) | 1998-08-18 |
| AR011577A1 (es) | 2000-08-30 |
| EP1001812A1 (en) | 2000-05-24 |
| RU2176499C2 (ru) | 2001-12-10 |
| KR100215027B1 (ko) | 1999-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9700241A (et) | Farmatseutiline kompositsioon transdermaalseks manustamiseks | |
| DE69713989D1 (de) | Fentanyl enthaltendes transdermal-pflaster | |
| DK0722736T3 (da) | Topisk sammensætning indeholdende en antagonist for substans P | |
| PT998272E (pt) | Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol | |
| PT1066027E (pt) | Composicao farmaceutica de topiramato | |
| ID22970A (id) | Komposisi perekat | |
| ID29994A (id) | Komposisi farmasi untuk melawan ccr5 terdiri dari turunan anilida | |
| FI973518L (fi) | Farmaseuttinen koostumus piperidinoalkanoliyhdisteille | |
| DE69530004D1 (de) | Transdermale verabreichung von apomorphin | |
| FI950774L (fi) | Valmiste käytettäväksi 3-ketodesogestreeliä sisältävään transdermaaliseen applikaatioon | |
| DK1035833T3 (da) | Sammensætning til nasal indgivelse | |
| DK0977612T3 (da) | Applikator til halvfaste medikamenter | |
| NO20021172D0 (no) | Farmasöytisk sammensetning | |
| PT907364E (pt) | Composicao farmaceutica de libertacao sustida | |
| EP0941039A4 (en) | TRANSDERMAL ADMINISTRATION OF 7alpha-METHYL-19-NORTESTOSTERONE ("MENT") | |
| BR9600216A (pt) | Formulação de emplastro de xanomelina transdérmica | |
| BR9607722A (pt) | Formulação transdérmica | |
| EE9900578A (et) | Tisoksaniidi ja nitasoksaniidi farmatseutilised kompositsioonid | |
| FI973229A0 (fi) | Uusi farmaseuttinen koostumus | |
| LV11727A (lv) | Farmaceitiska kompozicija | |
| MA26531A1 (fr) | Composition pharmaceutique | |
| AU4170299A (en) | Composition for the transdermal administration of non-steroidal anti-inflammatory drugs | |
| ID25857A (id) | Komposisi farmasi | |
| DE69821096D1 (de) | Pflaster-zubereitungen zur transdermalen absorption | |
| BR9709690A (pt) | Dispositivo destinados à administração transdérmica da trimegestona |